Fintel on MSN3d
William Blair Initiates Coverage of Altimmune (ALT) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...
William Blair Sticks to Their Hold Rating for Altimmune (ALT)
In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Altimmune (ALT – Research Report). The company’s shares ...
Altimmune initiated with a Market Perform at William Blair
William Blair analyst Andy Hsieh initiated coverage of Altimmune (ALT) with a Market Perform rating.Discover the Best Stocks and Maximize Your ...
Westminster Abbey6y
William Blair
It commemorates Royal Navy captains William Bayne, William Blair and Lord Robert Manners who were killed in 1782. On a column are relief portraits of all three with their names and ages (50, 41 and 24 ...
Yahoo Finance1mon
Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual ...
Morningstar2y
William Blair
William Blair has a ways to go to become an industry-standard steward, resulting in a Below Average Parent Pillar rating. Compared with peers, William Blair has had high portfolio management ...
Nasdaq4d
William Blair Initiates Coverage of Altimmune (LSE:0A4C) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (LSE:0A4C) with a Market Perform recommendation. There are 326 funds or institutions reporting positions in ...